©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Jun 26, 2017; 9(6): 531-538
Published online Jun 26, 2017. doi: 10.4330/wjc.v9.i6.531
Published online Jun 26, 2017. doi: 10.4330/wjc.v9.i6.531
Wearable cardioverter defibrillator: Bridge or alternative to implantation?
Jeremie Barraud, Jennifer Cautela, Morgane Orabona, Johan Pinto, Olivier Missenard, Marc Laine, Franck Thuny, Franck Paganelli, Laurent Bonello, Michael Peyrol, Department of Cardiology, Aix-Marseille University, Assistance Publique - Hôpitaux de Marseille, Nord Hospital, 13015 Marseille, France
Author contributions: Barraud J, Cautela J and Orabona M performed the majority of the writing; Pinto J and Missenard O prepared the figures and tables and performed the writing; Laine M, Thuny F and Paganelli F gave critical revision of the manuscript; Bonello L and Peyrol M designed the outline and coordinated the writing of the paper; all authors contributed critically to the drafts and gave final approval for publication.
Conflict-of-interest statement: The authors report no relationships that could be construed as a conflict of interest.
Correspondence to: Jeremie Barraud, MD, Department of Cardiology, Aix-Marseille University, Assistance Publique - Hôpitaux de Marseille, Nord Hospital, Chemin des Bourrelly, 13015 Marseille, France. jeremie.barraud@ap-hm.fr
Telephone: +33-491-968683 Fax: +33-491-968979
Received: November 29, 2016
Peer-review started: December 1, 2016
First decision: February 17, 2017
Revised: March 4, 2017
Accepted: April 18, 2017
Article in press: April 20, 2017
Published online: June 26, 2017
Processing time: 208 Days and 17.3 Hours
Peer-review started: December 1, 2016
First decision: February 17, 2017
Revised: March 4, 2017
Accepted: April 18, 2017
Article in press: April 20, 2017
Published online: June 26, 2017
Processing time: 208 Days and 17.3 Hours
Core Tip
Core tip: The wearable cardioverter defibrillator is increasingly used for sudden cardiac death prevention in patients thought to have a transient and/or reversible high risk for life-threatening ventricular arrhythmia. Evidences sustaining the use of this external device are growing. We provided an evidence base review in the light of new data.